Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 7.90% vs -3.42% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 34.49% vs -6.08% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 32.94% vs -0.64% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 29.88% vs -25.54% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of DHG Pharmaceutical JSC With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -3.25% vs -0.86% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 7.90% vs -3.42% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -11.53% vs -11.04% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 34.49% vs -6.08% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -10.17% vs -9.78% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 32.94% vs -0.64% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 52.71% vs 4.26% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 29.88% vs -25.54% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






